Tempus

Discover Personalized Healthcare Solutions with Tempus

Tempus is a cutting-edge digital health company that utilizes the power of artificial intelligence to provide individuals with personalized healthcare solutions. With a focus on cancer, Tempus has built the largest library of clinical and molecular data in the world.

Main Features:

• AI Clinical Assistant: Tempus One is an AI-powered clinical assistant designed to provide healthcare providers with instant access to patient insights using generative AI technology.
• Genomic Profiling: Tempus offers genomic profiling and algorithmic tests to empower physicians in making better-informed treatment decisions.
• Clinical Trial Matching: The platform enables fast and up-to-date searches for clinical trials based on specific criteria.
• Digital Pathology: Tempus provides digital pathology services, including Tempus Pixel, which aids in therapy response evaluation for various disease areas such as lung, breast, neuro, and cardio.
• Sequencing and Data Collaborations: Tempus offers sequencing services and promotes collaborations to enhance drug development.
• Clinical Research Services: Tempus assists in clinical trial enrollment and provides specialized services through Tempus PRO™ for neurology and psychiatry.
• EHR Integration: Tempus supports seamless data access and management through EHR integration.
• Publications: Stay updated with the latest developments in personalized healthcare through Tempus' regular research publications and webinars.

Use Cases:

• Providers: Tempus empowers physicians to make more informed treatment decisions.
• Life Sciences: Pharmaceutical and biotech companies benefit from Tempus' data-driven insights for improved drug development.
• Patients: Tempus helps patients discover personalized and optimal therapy options.

Notable Achievements:

• Tempus' xT Platform expands personalized therapeutic opportunities for cancer patients.
• Tempus' HLA-LOH assay received FDA Breakthrough Device Designation as a companion diagnostic (CDx) test.
• Tempus launched Tempus xR, a standalone RNA next-generation sequencing assay.
• Tempus has established partnerships with 90% of the top 20 pharma oncology companies and over 200 biopharma partners.
• Over 50% of all Academic Medical Centers and oncologists in the US have connected with Tempus.
• Tempus possesses a vast database of over 6,000,000+ de-identified research records, identifying 24,000+ potential patients for clinical trial enrollment.

Experience the power of personalized healthcare with Tempus and revolutionize the way treatment decisions are made. Give Tempus a try today!